Similar articles

• A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner.

  Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H. Sakai R, et al. EMBO J. 1994 Aug 15;13(16):3748-56. doi: 10.1002/j.1460-2075.1994.tb06684.x. EMBO J. 1994. PMID: 8070403 Free PMC article.
• Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.

  Matsuda M, Mayer BJ, Hanafusa H. Matsuda M, et al. Mol Cell Biol. 1991 Mar;11(3):1607-13. doi: 10.1128/mcb.11.3.1607-1613.1991. Mol Cell Biol. 1991. PMID: 1705010 Free PMC article.
• Possible v-Crk-induced transformation through activation of Src kinases.

  Sabe H, Shoelson SE, Hanafusa H. Sabe H, et al. J Biol Chem. 1995 Dec 29;270(52):31219-24. doi: 10.1074/jbc.270.52.31219. J Biol Chem. 1995. PMID: 8537387
• Viral T-antigen interactions with cellular proto-oncogene and anti-oncogene products.

  Schreier AA, Gruber J. Schreier AA, et al. J Natl Cancer Inst. 1990 Mar 7;82(5):354-60. doi: 10.1093/jnci/82.5.354. J Natl Cancer Inst. 1990. PMID: 2154582 Review. No abstract available.
• [Development of oncogene study].

  Toyoshima K. Toyoshima K. Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt 2):497-503. Gan To Kagaku Ryoho. 1983. PMID: 6309088 Review. Japanese.